Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical study of fosfomycin (CONTEPO) in pediatric patients with complicated urinary tract infections (cUTI)

Trial Profile

A clinical study of fosfomycin (CONTEPO) in pediatric patients with complicated urinary tract infections (cUTI)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2018

At a glance

  • Drugs Fosfomycin (Primary)
  • Indications Urinary tract infections
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Jul 2018 New trial record
    • 24 Jul 2018 According to a Nabriva Therapeutics media release, this study has been initiated.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top